메뉴 건너뛰기




Volumn 15, Issue 5, 2013, Pages

Cigarette smoking and clopidogrel interaction

Author keywords

Acute coronary syndrome; Adenosine diphosphate receptor antagonist; Clopidogrel; Dual antiplatelet therapy; High on treatment platelet reactivity; Percutaneous coronary intervention; Percutaneous revascularization; Prasugrel; Smoking; Ticagrelor; Tobacco use

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; COTININE; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINE; PLACEBO; POLYCYCLIC AROMATIC HYDROCARBON; PRASUGREL; PROTON PUMP INHIBITOR; TICAGRELOR;

EID: 84876119882     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0361-7     Document Type: Article
Times cited : (15)

References (80)
  • 1
    • 84862505462 scopus 로고    scopus 로고
    • Differential effect of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: Insights from the Clopidogrel vs Aspirin in Patients at Risk of Ischemic Events Trial [Abstract]
    • Ferreiro J, Bhatt D, Ueno M. Differential effect of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the Clopidogrel vs Aspirin in Patients at Risk of Ischemic Events Trial [Abstract]. J Am Coll Cardiol. 2012;59:A62.
    • (2012) J Am Coll Cardiol. , vol.59
    • Ferreiro, J.1    Bhatt, D.2    Ueno, M.3
  • 2
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • DOI 10.1056/NEJMoa010746
    • Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502. (Pubitemid 32758501)
    • (2001) New England Journal of Medicine , vol.345 , Issue.7 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 3
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • DOI 10.1161/01.CIR.0000072771.11429.83
    • Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003;107:2908-13. (Pubitemid 36736631)
    • (2003) Circulation , vol.107 , Issue.23 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3    O'Connor, C.M.4
  • 4
    • 68149180722 scopus 로고    scopus 로고
    • Recent developments in clopidogrel pharmacology and their relation to clinical outcomes
    • Gurbel PA, Antonino MJ, Tantry US. Recent developments in clopidogrel pharmacology and their relation to clinical outcomes. Expert Opin Drug Metab Toxicol. 2009;5:989-1004.
    • (2009) Expert Opin Drug Metab Toxicol. , vol.5 , pp. 989-1004
    • Gurbel, P.A.1    Antonino, M.J.2    Tantry, U.S.3
  • 5
    • 8344221349 scopus 로고    scopus 로고
    • Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
    • Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109:3171-5.
    • (2004) Circulation. , vol.109 , pp. 3171-3175
    • Matetzky, S.1    Shenkman, B.2    Guetta, V.3    Shechter, M.4    Beinart, R.5    Goldenberg, I.6
  • 7
    • 77953911457 scopus 로고    scopus 로고
    • Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate
    • Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56:919-33.
    • (2010) J Am Coll Cardiol. , vol.56 , pp. 919-933
    • Bonello, L.1    Tantry, U.S.2    Marcucci, R.3    Blindt, R.4    Angiolillo, D.J.5    Becker, R.6
  • 9
    • 80052167250 scopus 로고    scopus 로고
    • Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data
    • Brar SS, ten Berg J, Marcucci R, Price MJ, Valgimigli M, Kim HS, et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol. 2011;58:1945-54.
    • (2011) J Am Coll Cardiol. , vol.58 , pp. 1945-1954
    • Brar, S.S.1    Ten Berg, J.2    Marcucci, R.3    Price, M.J.4    Valgimigli, M.5    Kim, H.S.6
  • 11
    • 70349868299 scopus 로고    scopus 로고
    • Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy
    • Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy. Thromb Res. 2009;124:588-91.
    • (2009) Thromb Res. , vol.124 , pp. 588-591
    • Gremmel, T.1    Steiner, S.2    Seidinger, D.3    Koppensteiner, R.4    Panzer, S.5    Kopp, C.W.6
  • 12
    • 65449170730 scopus 로고    scopus 로고
    • Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention
    • Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2009;103:1339-43.
    • (2009) Am J Cardiol. , vol.103 , pp. 1339-1343
    • Price, M.J.1    Nayak, K.R.2    Barker, C.M.3    Kandzari, D.E.4    Teirstein, P.S.5
  • 13
    • 67650901939 scopus 로고    scopus 로고
    • Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: Statin's advantage and the smoking "paradox"
    • Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, et al. Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox". J Cardiovasc Pharmacol. 2009;53:368-72.
    • (2009) J Cardiovasc Pharmacol. , vol.53 , pp. 368-372
    • Motovska, Z.1    Widimsky, P.2    Petr, R.3    Bilkova, D.4    Marinov, I.5    Simek, S.6
  • 15
    • 77957172636 scopus 로고    scopus 로고
    • Smoking at least 10 cigarettes per day increases platelet inhibition by clopidogrel in patients with ST-segment-elevation myocardial infarction
    • Jeong YH, Cho JH, Kang MK, Koh JS, Kim IS, Park Y, et al. Smoking at least 10 cigarettes per day increases platelet inhibition by clopidogrel in patients with ST-segment-elevation myocardial infarction. Thromb Res. 2010;126:e334-8.
    • (2010) Thromb Res. , vol.126
    • Jeong, Y.H.1    Cho, J.H.2    Kang, M.K.3    Koh, J.S.4    Kim, I.S.5    Park, Y.6
  • 16
    • 84876807915 scopus 로고    scopus 로고
    • Impact of smoking-cessation on platelet inhibition of clopidogrel in patients undergoing elective coronary drug-eluting stent implantation short term smoking cessation
    • (GWICC abstract)
    • Liu X, Zhou Y, Yang Q. Impact of smoking-cessation on platelet inhibition of clopidogrel in patients undergoing elective coronary drug-eluting stent implantation short term smoking cessation. Heart. 2010;96:(GWICC abstract).
    • (2010) Heart. , vol.96
    • Liu, X.1    Zhou, Y.2    Yang, Q.3
  • 17
    • 79960189314 scopus 로고    scopus 로고
    • The effect of ticagrelor vs clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies
    • Bliden KP, Tantry US, Storey RF, Jeong YH, Gesheff M, Wei C, et al. The effect of ticagrelor vs clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies. Am Heart J. 2011;162:160-5.
    • (2011) Am Heart J. , vol.162 , pp. 160-165
    • Bliden, K.P.1    Tantry, U.S.2    Storey, R.F.3    Jeong, Y.H.4    Gesheff, M.5    Wei, C.6
  • 18
    • 79952192512 scopus 로고    scopus 로고
    • Enhanced clopidogrel responsiveness in smokers: Smokers' paradox is dependent on cytochrome P450 CYP1A2 status
    • Park KW, Park JJ, Jeon KH, Kang SH, Oh IY, Yang HM, et al. Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 status. Arterioscl Thromb Vasc Biol. 2011;31:665-71.
    • (2011) Arterioscl Thromb Vasc Biol. , vol.31 , pp. 665-671
    • Park, K.W.1    Park, J.J.2    Jeon, K.H.3    Kang, S.H.4    Oh, I.Y.5    Yang, H.M.6
  • 19
    • 54949144309 scopus 로고    scopus 로고
    • Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
    • Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008;392:1093-108.
    • (2008) Anal Bioanal Chem. , vol.392 , pp. 1093-1108
    • Zanger, U.M.1    Turpeinen, M.2    Klein, K.3    Schwab, M.4
  • 20
    • 84862504147 scopus 로고    scopus 로고
    • Clopidogrel efficacy and cigarette smoking status
    • Gurbel PA, Nolin T. Clopidogrel efficacy and cigarette smoking status. JAMA. 2012;307:2495-6.
    • (2012) JAMA. , vol.307 , pp. 2495-2496
    • Gurbel, P.A.1    Nolin, T.2
  • 21
    • 33748937559 scopus 로고    scopus 로고
    • Smoking influences the effectiveness of dual antiplatelet therapy on long-term outcomes following PCI
    • (Abstract 2920-122)
    • Saraff K. Smoking influences the effectiveness of dual antiplatelet therapy on long-term outcomes following PCI. J Am Coll Cardiol. 2006:36B:(Abstract 2920-122).
    • (2006) J Am Coll Cardiol. , vol.36
    • Saraff, K.1
  • 22
    • 73449139419 scopus 로고    scopus 로고
    • Smoking, clopidogrel, and mortality in patients with established cardiovascular disease
    • Berger JS, Bhatt DL, Steinhubl SR, Shao M, Steg PG, Montalescot G, et al. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation. 2009;120:2337-44.
    • (2009) Circulation. , vol.120 , pp. 2337-2344
    • Berger, J.S.1    Bhatt, D.L.2    Steinhubl, S.R.3    Shao, M.4    Steg, P.G.5    Montalescot, G.6
  • 25
    • 84862493269 scopus 로고    scopus 로고
    • Relationship between clopidogrel and cigarette smoking status in patients with acute coronary syndromes without ST-segment elevation myocardial infarction. Abstract 8
    • Salek F. Relationship between clopidogrel and cigarette smoking status in patients with acute coronary syndromes without ST-segment elevation myocardial infarction. Abstract 8. Pharmacotherapy. 2010;30:154e.
    • (2010) Pharmacotherapy. , vol.30
    • Salek, F.1
  • 26
    • 77958005516 scopus 로고    scopus 로고
    • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial
    • Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet. 2010;376:1233-43.
    • (2010) Lancet. , vol.376 , pp. 1233-1243
    • Mehta, S.R.1    Tanguay, J.F.2    Eikelboom, J.W.3    Jolly, S.S.4    Joyner, C.D.5    Granger, C.B.6
  • 28
    • 80052292634 scopus 로고    scopus 로고
    • Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy
    • Hochholzer W, Trenk D, Mega JL, Morath T, Stratz C, Valina CM, et al. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy. Am Heart J. 2011;162:518-26.e5.
    • (2011) Am Heart J. , vol.162 , pp. 518-526
    • Hochholzer, W.1    Trenk, D.2    Mega, J.L.3    Morath, T.4    Stratz, C.5    Valina, C.M.6
  • 30
    • 0015890897 scopus 로고
    • An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis
    • Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation. 1973;48:619-23.
    • (1973) Circulation. , vol.48 , pp. 619-623
    • Levine, P.H.1
  • 31
    • 0028828489 scopus 로고
    • Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin
    • Hung J, Lam JY, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation. 1995;92:2432-6.
    • (1995) Circulation. , vol.92 , pp. 2432-2436
    • Hung, J.1    Lam, J.Y.2    Lacoste, L.3    Letchacovski, G.4
  • 32
    • 0033596924 scopus 로고    scopus 로고
    • Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction
    • Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation. 1999;99:1411-5. (Pubitemid 29140904)
    • (1999) Circulation , vol.99 , Issue.11 , pp. 1411-1415
    • Newby, D.E.1    Wright, R.A.2    Labinjoh, C.3    Ludlam, C.A.4    Fox, K.A.A.5    Boon, N.A.6    Webb, D.J.7
  • 33
    • 0014315640 scopus 로고
    • Prognosis of men after first myocardial infarction: Mortality and first recurrence in relation to selected parameters
    • Weinblatt E, Shapiro S, Frank CW, Sager RV. Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Pub Health Nation's Health. 1968;58:1329-47.
    • (1968) Am J Pub Health Nation's Health. , vol.58 , pp. 1329-1347
    • Weinblatt, E.1    Shapiro, S.2    Frank, C.W.3    Sager, R.V.4
  • 34
    • 0015782977 scopus 로고
    • Short and long-term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit
    • Helmers C. Short and long-term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit. Acta Med Scand. Suppl 1973;555:7-26.
    • (1973) Acta Med Scand. Suppl , vol.555 , pp. 7-26
    • Helmers, C.1
  • 35
    • 0022189646 scopus 로고
    • Smoking status at the time of acute myocardial infarction and subsequent prognosis
    • DOI 10.1016/0002-8703(85)90071-7
    • Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J. 1985;110:535-41. (Pubitemid 16031168)
    • (1985) American Heart Journal , vol.110 , Issue.3 , pp. 535-541
    • Kelly, T.L.1    Gilpin, E.2    Ahnve, S.3
  • 36
    • 0035859945 scopus 로고    scopus 로고
    • Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: Another smoker's paradox?
    • Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ, Kuntz RE. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation. 2001;104:773-8. (Pubitemid 32762674)
    • (2001) Circulation , vol.104 , Issue.7 , pp. 773-778
    • Cohen, D.J.1    Doucet, M.2    Cutlip, D.E.3    Ho, K.K.L.4    Popma, J.J.5    Kuntz, R.E.6
  • 37
    • 0031049589 scopus 로고    scopus 로고
    • Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization
    • DOI 10.1056/NEJM199703133361103
    • Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336:755-61. (Pubitemid 27113969)
    • (1997) New England Journal of Medicine , vol.336 , Issue.11 , pp. 755-761
    • Hasdai, D.1    Garratt, K.N.2    Grill, D.E.3    Lerman, A.4    Holmes Jr., D.R.5
  • 38
    • 0028962712 scopus 로고
    • Acute myocardial infarction in the young-The role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial
    • Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Acute myocardial infarction in the young-the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J. 1995;16:313-6.
    • (1995) Eur Heart J. , vol.16 , pp. 313-316
    • Barbash, G.I.1    White, H.D.2    Modan, M.3    Diaz, R.4    Hampton, J.R.5    Heikkila, J.6
  • 39
    • 80052035934 scopus 로고    scopus 로고
    • The "smoker's paradox" in patients with acute coronary syndrome: A systematic review
    • Aune E, Røislien J, Mathisen M, Thelle DS, Otterstad JE. The "smoker's paradox" in patients with acute coronary syndrome: a systematic review. BMC Med. 2011;9:97.
    • (2011) BMC Med. , vol.9 , pp. 97
    • Aune, E.1    Røislien, J.2    Mathisen, M.3    Thelle, D.S.4    Otterstad, J.E.5
  • 41
    • 0033973850 scopus 로고    scopus 로고
    • Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers
    • DOI 10.1016/S0049-3848(99)00137-1, PII S0049384899001371
    • Fusegawa Y, Handa S. Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Thromb Res. 2000;97:287-95. (Pubitemid 30089033)
    • (2000) Thrombosis Research , vol.97 , Issue.5 , pp. 287-295
    • Fusegawa, Y.1    Handa, S.2
  • 42
    • 77449149717 scopus 로고    scopus 로고
    • Platelet adenosine diphosphate P2Y12 receptor antagonism: Benefits and limitations of current treatment strategies and future directions
    • Angiolillo DJ, Ferreiro JL. Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions. Rev Esp Cardiol. 2010;63:60-76.
    • (2010) Rev Esp Cardiol. , vol.63 , pp. 60-76
    • Angiolillo, D.J.1    Ferreiro, J.L.2
  • 44
    • 80053289254 scopus 로고    scopus 로고
    • The evolution of antiplatelet therapy in cardiovascular disease
    • Yousuf O, Bhatt DL. The evolution of antiplatelet therapy in cardiovascular disease. Nat Rev Cardiol. 2011;8:547-59.
    • (2011) Nat Rev Cardiol. , vol.8 , pp. 547-559
    • Yousuf, O.1    Bhatt, D.L.2
  • 45
    • 0034691260 scopus 로고    scopus 로고
    • Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
    • Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation. 2000;101:2823-8. (Pubitemid 30396013)
    • (2000) Circulation , vol.101 , Issue.24 , pp. 2823-2828
    • Cadroy, Y.1    Bossavy, J.-P.2    Thalamas, C.3    Sagnard, L.4    Sakariassen, K.5    Boneu, B.6
  • 46
    • 0033866804 scopus 로고    scopus 로고
    • Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy
    • Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, et al. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol. 2000;36:699-705.
    • (2000) J Am Coll Cardiol. , vol.36 , pp. 699-705
    • Moshfegh, K.1    Redondo, M.2    Julmy, F.3    Wuillemin, W.A.4    Gebauer, M.U.5    Haeberli, A.6
  • 47
    • 0035252921 scopus 로고    scopus 로고
    • Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement
    • DOI 10.1016/S0002-9149(00)01369-2, PII S0002914900013692
    • Gawaz M, Seyfarth M, Muller I, Rudiger S, Pogatsa-Murray G, Wolf B, et al. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. Am J Cardiol. 2001;87:332-6. A9. (Pubitemid 32144877)
    • (2001) American Journal of Cardiology , vol.87 , Issue.3 , pp. 332-336
    • Gawaz, M.1    Seyfarth, M.2    Muller, I.3    Rudiger, S.4    Pogatsa-Murray, G.5    Wolf, B.6    Schomig, A.7
  • 48
    • 70350025236 scopus 로고    scopus 로고
    • CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: Implications for its monitoring
    • Aleil B, Léon C, Cazenave J-P, Gachet C. CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: implications for its monitoring. J Thromb Haemost JTH. 2009;7:1747-9.
    • (2009) J Thromb Haemost JTH. , vol.7 , pp. 1747-1749
    • Aleil, B.1    Léon, C.2    Cazenave, J.-P.3    Gachet, C.4
  • 50
    • 0038508970 scopus 로고    scopus 로고
    • The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin
    • DOI 10.1124/dmd.31.1.53
    • Clarke TA, Waskell LA. The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin. Drug Metab Dispos. 2003;31:53-9. (Pubitemid 36735258)
    • (2003) Drug Metabolism and Disposition , vol.31 , Issue.1 , pp. 53-59
    • Clarke, T.A.1    Waskell, L.A.2
  • 52
    • 69249219296 scopus 로고    scopus 로고
    • Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
    • Shuldiner A, O'Connell J. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA. 2009;302:849-57.
    • (2009) JAMA. , vol.302 , pp. 849-857
    • Shuldiner, A.1    O'Connell, J.2
  • 53
    • 33749339075 scopus 로고    scopus 로고
    • Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
    • DOI 10.1182/blood-2006-04-013052
    • Hulot JS, Bura A, Villard E, Azizi M, Remones V, Goyenvalle C, et al. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood. 2006;108:2244-7. (Pubitemid 44497506)
    • (2006) Blood , vol.108 , Issue.7 , pp. 2244-2247
    • Hulot, J.-S.1    Bura, A.2    Villard, E.3    Azizi, M.4    Remones, V.5    Goyenvalle, C.6    Aiach, M.7    Lechat, P.8    Gaussem, P.9
  • 55
    • 58249135635 scopus 로고    scopus 로고
    • Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study
    • Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet. 2009;373:309-17.
    • (2009) Lancet. , vol.373 , pp. 309-317
    • Collet, J.P.1    Hulot, J.S.2    Pena, A.3    Villard, E.4    Esteve, J.B.5    Silvain, J.6
  • 58
    • 0036667961 scopus 로고    scopus 로고
    • The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors
    • DOI 10.1097/00008571-200208000-00008
    • Rasmussen BB, Brix TH, Kyvik KO, Brøsen K. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics. 2002;12:473-8. (Pubitemid 34913530)
    • (2002) Pharmacogenetics , vol.12 , Issue.6 , pp. 473-478
    • Rasmussen, B.B.1    Brix, T.H.2    Kyvik, K.O.3    Brosen, K.4
  • 59
    • 77951447009 scopus 로고    scopus 로고
    • Structure, function, regulation, and polymorphism and the clinical significance of human cytochrome P450 1A2
    • Zhou S-F, Wang B, Yang L-P, Liu J-P. Structure, function, regulation, and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev. 2010;42:268-354.
    • (2010) Drug Metab Rev. , vol.42 , pp. 268-354
    • Zhou, S.-F.1    Wang, B.2    Yang, L.-P.3    Liu, J.-P.4
  • 61
    • 0032908778 scopus 로고    scopus 로고
    • Functional significance of a C→A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine
    • DOI 10.1046/j.1365-2125.1999.00898.x
    • Sachse C, Brockmöller J, Bauer S, Roots I. Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol. 1999;47:445-9. (Pubitemid 29161279)
    • (1999) British Journal of Clinical Pharmacology , vol.47 , Issue.4 , pp. 445-449
    • Sachse, C.1    Brockmoller, J.2    Bauer, S.3    Roots, I.4
  • 62
    • 49849097496 scopus 로고    scopus 로고
    • Smoking behavior modulates pharmacokinetics of orally administered clopidogrel
    • Yousef A-M, Arafat T, Bulatova NR, Al-Zumyli R. Smoking behavior modulates pharmacokinetics of orally administered clopidogrel. J Clin Pharmacol Ther. 2008;33:439-49.
    • (2008) J Clin Pharmacol Ther. , vol.33 , pp. 439-449
    • Yousef, A.-M.1    Arafat, T.2    Bulatova, N.R.3    Al-Zumyli, R.4
  • 64
    • 78650720489 scopus 로고    scopus 로고
    • Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes
    • Washio I, Maeda M, Sugiura C, Shiga R, Yoshida M, Nonen S, et al. Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes. DrugMetab Dispos. 2011;39:1-3.
    • (2011) DrugMetab Dispos. , vol.39 , pp. 1-3
    • Washio, I.1    Maeda, M.2    Sugiura, C.3    Shiga, R.4    Yoshida, M.5    Nonen, S.6
  • 66
    • 84858754393 scopus 로고    scopus 로고
    • Cigarette smoking is associated with a doseresponse effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease. Results of a pharmacodynamic study
    • Ueno M, Ferreiro JL, Desai B, Tomasello SD, Tello-Montoliu A, Capodanno D, et al. Cigarette smoking is associated with a doseresponse effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease. Results of a pharmacodynamic study. JACC. 2012;5:293-300.
    • (2012) JACC. , vol.5 , pp. 293-300
    • Ueno, M.1    Ferreiro, J.L.2    Desai, B.3    Tomasello, S.D.4    Tello-Montoliu, A.5    Capodanno, D.6
  • 67
    • 77950983043 scopus 로고    scopus 로고
    • The impact of smoking on post-clopidogrel platelet reactivity in patients with acute myocardial infarction
    • Cho JH, Jeong YH, Ahn YJ, Kang MK, Koh JS, Kim IS, et al. The impact of smoking on post-clopidogrel platelet reactivity in patients with acute myocardial infarction. Korean Circ J. 2010;40:119-24.
    • (2010) Korean Circ J. , vol.40 , pp. 119-124
    • Cho, J.H.1    Jeong, Y.H.2    Ahn, Y.J.3    Kang, M.K.4    Koh, J.S.5    Kim, I.S.6
  • 68
    • 37549006004 scopus 로고    scopus 로고
    • The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score
    • Geisler T, Grass D, Bigalke B, Stellos K, Drosch T, DietzK, et al. The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score. J Thrombd Haemost JTH. 2008;6:54-61.
    • (2008) J Thrombd Haemost JTH. , vol.6 , pp. 54-61
    • Geisler, T.1    Grass, D.2    Bigalke, B.3    Stellos, K.4    Dietzk, D.T.5
  • 69
    • 78649373563 scopus 로고    scopus 로고
    • Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events
    • Sibbald M, Yan AT, Huang W, Fox KA, Gore JM, Steg PG, et al. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2010;160:855-61.
    • (2010) Am Heart J. , vol.160 , pp. 855-861
    • Sibbald, M.1    Yan, A.T.2    Huang, W.3    Fox, K.A.4    Gore, J.M.5    Steg, P.G.6
  • 70
    • 68249144596 scopus 로고    scopus 로고
    • The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: A TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel- Thrombolysis in Myocardial Infarction 38) analysis
    • O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel- Thrombolysis In Myocardial Infarction 38) analysis. J Am Coll Cardiol. 2009;54:678-85.
    • (2009) J Am Coll Cardiol. , vol.54 , pp. 678-685
    • O'Donoghue, M.1    Antman, E.M.2    Braunwald, E.3    Murphy, S.A.4    Steg, P.G.5    Finkelstein, A.6
  • 72
    • 3543019165 scopus 로고    scopus 로고
    • Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
    • DOI 10.1016/j.clpt.2004.04.003, PII S0009923604001286
    • Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76:178-84. (Pubitemid 39013407)
    • (2004) Clinical Pharmacology and Therapeutics , vol.76 , Issue.2 , pp. 178-184
    • Faber, M.S.1    Fuhr, U.2
  • 73
    • 84862019325 scopus 로고    scopus 로고
    • Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: Additional evidence for the concept of 'smokers' paradox'
    • ParkKW, Kang SH, Kang J, Jeon KH, Park JJ, Han JK, et al. Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of 'smokers' paradox'. Heart. 2012;98:1000-6.
    • (2012) Heart. , vol.98 , pp. 1000-1006
    • Parkkw Kang, S.H.1    Kang, J.2    Jeon, K.H.3    Park, J.J.4    Han, J.K.5
  • 74
    • 77958105401 scopus 로고    scopus 로고
    • Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: A pharmacogenetic analysis
    • Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet. 2010;376:1312-9.
    • (2010) Lancet. , vol.376 , pp. 1312-1319
    • Mega, J.L.1    Close, S.L.2    Wiviott, S.D.3    Shen, L.4    Walker, J.R.5    Simon, T.6
  • 75
    • 84895907642 scopus 로고    scopus 로고
    • TCT-54 the influence of smoking status on the pharmacodynamics of prasugrel and clopidogrel: The PARADOX Study
    • (Abstract)
    • Gurbel P, Bliden K, Logan D, Al. E. TCT-54 The influence of smoking status on the pharmacodynamics of prasugrel and clopidogrel: the PARADOX Study. J Am Coll Cardiol. 2012;60(17 Suppl): (Abstract).
    • (2012) J Am Coll Cardiol. , vol.60 , Issue.17 SUPPL.
    • Gurbel, P.1    Bliden, K.2    Logan, D.3
  • 76
    • 84866325657 scopus 로고    scopus 로고
    • Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes. Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
    • e1
    • Cornel JH, Becker RC, Goodman SG, Husted S, Katus H, Santoso A, et al. Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes. Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J. 2012;164:334-42.e1.
    • (2012) Am Heart J. , vol.164 , pp. 334-342
    • Cornel, J.H.1    Becker, R.C.2    Goodman, S.G.3    Husted, S.4    Katus, H.5    Santoso, A.6
  • 77
    • 84876798728 scopus 로고    scopus 로고
    • CYP1A2-inducing medications improve platelet responsiveness to clopidrogrel
    • Abstract 58
    • Gengo F, Robson M, Rainka M. CYP1A2-inducing medications improve platelet responsiveness to clopidrogrel. J Clini Pharmacol. 2010;50:1069. Abstract 58.
    • (2010) J Clini Pharmacol. , vol.50 , pp. 1069
    • Gengo, F.1    Robson, M.2    Rainka, M.3
  • 78
    • 84895906489 scopus 로고    scopus 로고
    • Serum cotinine levels are associated with increased clopidrogrel-induced antiplatelet effects in patients with diabetes mellitus and coronary artery disease
    • Ueno M, Ferreiro J, Dharmashankar K, Tomasselo S. Serum cotinine levels are associated with increased clopidrogrel-induced antiplatelet effects in patients with diabetes mellitus and coronary artery disease. New Orleans: American College of Cardiology (ACC); 2011.
    • New Orleans: American College of Cardiology (ACC) , vol.2011
    • Ueno, M.1    Ferreiro, J.2    Dharmashankar, K.3    Tomasselo, S.4
  • 79
    • 60949083948 scopus 로고    scopus 로고
    • Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis
    • Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009;53:849-56.
    • (2009) J Am Coll Cardiol. , vol.53 , pp. 849-856
    • Sibbing, D.1    Braun, S.2    Morath, T.3    Mehilli, J.4    Vogt, W.5    Schömig, A.6
  • 80
    • 0030590746 scopus 로고    scopus 로고
    • Anon. A randomized, blinded, trial of clopidogrel vs aspirin in patients at risk of ischemic events (CAPRIE)
    • CAPRIE Steering Committee
    • Anon. A randomized, blinded, trial of clopidogrel vs aspirin in patients at risk of ischemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-39.
    • (1996) Lancet. , vol.348 , pp. 1329-1339


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.